Dr. med. Jakob Rudzki

• +43 (512) 504-82157
• +43 (512) 570485-44
• Jakob.Rudzki@i-med.ac.at

list of publications

Dose escalation of imatinib in chronic-phase chronic myeloid leukemia patients: is it still reasonable?

Rudzki J, Wolf D.

Expert Rev Hematol. 4 Apr 2011; 4(2)153-9.

Current treatment concepts of Philadelphia-negative MPN

Wolf D, Rudzki J, Gastl G.

Curr Cancer Drug Targets 1 Jan 2011; 11(1)44-55.